Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST‐1
- 1 July 1993
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 23 (7) , 1494-1500
- https://doi.org/10.1002/eji.1830230715
Abstract
The pathogenesis of the toxic shock syndrome (TSS) is only incompletely understood. We now present evidence that TSS toxin‐1 (TSST‐1), one of the superantigens produced by Staphylococcus aureus, induces lethal shock in D‐galactosamine sensitized mice. In this model TSS is dependent on T cells, since cyclosporin A (CsA) completely blocked development of shock, and since T cell‐deficient SCID mice did not show signs of disease upon injection with TSST‐1. However, SCID mice repopulated with T cells succumbed to lethal shock. The disease is characterized by a burst of lymphokines like interleukin‐2 (IL‐2) and tumor necrosis factor (TNF) released into the sera of TSST‐1‐treated animals. Already 1–2 h after TSST‐1 application TNF serum levels peaked and IL‐2 levels peaked around 4 h after treatment. TNF appears as key mediator of TSS, because anti‐TNF monoclonal antibodies protected TSST‐1‐challenged mice. Interestingly, the burst of TNF in serum was noted well in advance of detectable markers of T cell activation. Thus, about 5 % of all peripheral T cells started to express the IL‐2 receptors as late as 4 h after treatment. Comparing TSST‐1‐ and endotoxin‐induced shock we conclude that TNF effects shock in both diseases. However, the type of cells involved appears distinct in that T cells cause TSS triggered by the exotosin TSST‐1 while macrophages mediate the shock induced by endotoxins.Keywords
This publication has 58 references indexed in Scilit:
- T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor.The Journal of Experimental Medicine, 1992
- The open reading frames in the 3' long terminal repeats of several mouse mammary tumor virus integrants encode V beta 3-specific superantigens.The Journal of Experimental Medicine, 1992
- Mls — a retrovirus exploits the immune systemImmunology Today, 1991
- Binding of toxic shock syndrome toxin‐1 to murine major histocompatibility complex class II moleculesEuropean Journal of Immunology, 1990
- Selective expansion of T cells expressing V beta 2 in toxic shock syndrome.The Journal of Experimental Medicine, 1990
- The Staphylococcal Enterotoxins and Their RelativesScience, 1990
- Mediators in the Pathogenesis of Toxic Shock Syndrome: OverviewClinical Infectious Diseases, 1989
- The Vβ-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal miceCell, 1989
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985
- Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2European Journal of Immunology, 1981